Safal Lifescience Private Limited

Safal Lifescience Private Limited - pharma in Kadi, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2016PTC092075 Incorporated 19 May 2016 ROC Ahmedabad HQ Kadi, Gujarat, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹29.37 Cr
▲ 65% YoY
Net loss · FY 2025
₹10.1 Lakh
Net margin -0.3%
EBITDA · FY 2025
₹3.2 Cr
EBITDA margin 10.9%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Satisfied charges
₹9.5 Cr
No open charges
Company age
10 yrs
Est. 2016
Employees · EPFO
50
Provident fund records

About Safal Lifescience Private Limited

Data last updated:

Safal Lifescience Private Limited is a private limited company based in Kadi, Gujarat, India, a subsidiary of Newtronic Lifecare Equipment Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 May 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2016PTC092075. Its GSTIN is 24AAXCS1015M1Z1 (Gujarat). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. It is led by directors Jignesh Navinchandra Mehta and Navinbhai Manilal Mehta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 414/3 Near Hitachi Company Kadi – Kalol Road Behind Karannagar Petrol Pump Indrad Ta, Kadi, Gujarat, India – 382715.

As per the financials filed for FY 2025, the company reported a revenue of ₹29.37 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net loss of ₹10.1 Lakh (net margin -0.3%) and EBITDA of ₹3.2 Cr (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years and 44% over five years.

The company has about 50 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹9.5 Cr on record. Court records list 29 cases involving the company, including 5 filed by the company and 24 filed against it; 6 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2020. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Meditech Devices Private Limited with revenue of ₹29.4 Cr. The company has 4 MSME Form 1 returns on record between 2020 and 2022, listing 274 overdue payments to 18 micro and small suppliers.

Safal Lifescience Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0002057). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website safallifescience.com.

Company details

CIN U24230GJ2016PTC092075
Registration Number 092075
Incorporation Date 19 May 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Newtronic Lifecare Equipment Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-14-0002057
Key People
Jignesh Navinchandra Mehta Director Navinbhai Manilal Mehta Director

Recognitions & Rankings of Safal Lifescience

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-14-0002057

Contact details

Safal Lifescience Private Limited's registered office is in Kadi, Gujarat. Its website is safallifescience.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    safallifescience.com
  • Registered Address
    414/3 Near Hitachi Company Kadi – Kalol Road Behind Karannagar Petrol Pump Indrad Ta, Kadi, Gujarat, India – 382715
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Safal Lifescience Private Limited, buy the company report.

Comprehensive company report
Safal Lifescience Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Safal Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Safal Lifescience Private Limited, buy the company report.

Financials of Safal Lifescience Private Limited

FY 2025 filings available

Safal Lifescience Private Limited reported revenue of ₹29.37 Cr (up 65% YoY) for FY 2025.

Revenue · FY 2025
₹29.37 Cr ▲ 65%
Net loss · FY 2025
₹10.1 Lakh margin -0.3%
EBITDA · FY 2025
₹3.2 Cr margin 10.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 65%
3 years · compounded
▲ 49%
5 years · compounded
▲ 44%
EBITDA CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 50%
5 years · compounded
▲ 28%

Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 65% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.2 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹10.1 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.9%
Net Profit Margin-0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Safal Lifescience Private Limited, buy the company report.

Board of directors of Safal Lifescience Private Limited

Safal Lifescience has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jignesh Navinchandra Mehta
Also directs: Navjish Venture Private Limited, Newtronic Lifecare Equipment Private Limited
Director02 Apr 20197 Years 7 MonthsCurrent
Navinbhai Manilal Mehta
Also directs: Navjish Venture Private Limited, Newtronic Lifecare Equipment Private Limited
Director02 Apr 20197 Years 7 MonthsCurrent
View all directors

Peer comparison

Safal Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Meditech Devices Private Limited₹29.4 Cr (FY 2025)18.0%Ahmedabad, Gujarat, India
Neel Pigments Private Limited₹29.4 Cr (FY 2025)41.0%Ankleshwar, Gujarat, India
Goodie International Private Limited₹29.4 Cr (FY 2025)-1.0%Gurgaon, Haryana, India
KSJN Chemicals Private Limited₹29.39 Cr (FY 2025)-23.0%Delhi, India
Rapross Pharmaceuticals Private Limited₹29.39 Cr (FY 2023)3.0%Delhi, India
Safal Lifescience Private Limitedthis company₹29.37 Cr (FY 2025)-₹10.1 Lakh-0.3%65.0%50Kadi, Gujarat, India
G.M. Chemie Private Limited₹29.36 Cr (FY 2025)43.0%Navi Mumbai, Maharashtra, India
Ecoearth Biopol Private Limited₹29.36 Cr (FY 2025)48.0%Kanpur, Uttar Pradesh, India
Uv Lifecare Limited₹29.35 Cr (FY 2025)23.0%Panchkula, Haryana, India
Septodont Healthcare India Private Limited₹29.35 Cr (FY 2025)-2.0%Navi Mumbai, Maharashtra, India
Millennium Herbal Care Limited₹29.32 Cr (FY 2025)-9.0%Mumbai, Maharashtra, India

To see the full peer comparison of Safal Lifescience Private Limited, buy the company report.

Auditor

Safal Lifescience Private Limited is audited by SHAH SANGHVI & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
SHAH SANGHVI & ASSOCIATESFY 2022140107W

Shareholding

The shareholding of Safal Lifescience Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Safal Lifescience Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹9.5 Cr
Breakdown by lending institutions
State Bank of India₹9.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
19 Apr 2018100171479State Bank of India₹9.5 CrSatisfied

To see the full charge records of Safal Lifescience Private Limited, buy the company report.

Total charge records: 1 View all charges

Deals & funding

Safal Lifescience Private Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2020.

Total deals
3
Secondary share transfers
2
Rights issue
1

Deals on record (3 of 3)

WhenDealAmountParties
Mar 2020Secondary share transferUndisclosedBuyer: Newtronic Lifecare Equipment Private Limited , 2 individuals
Seller: 4 individuals
Apr 2019Secondary share transferUndisclosedBuyer: Newtronic Lifecare Equipment Private Limited , 2 individuals
Seller: 2 individuals
Oct 2017Rights issue₹3.99 CrInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Safal Lifescience Private Limited has 4 MSME Form 1 returns on record between 2020 and 2022, listing 274 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 18)

SupplierAmount dueDue sinceReported on
Rakesh Chemicals Chhatral
an individual supplier
an individual supplier
an individual supplier
Rihaan Packaging Private Limited

To see the full MSME payment records of Safal Lifescience Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Safal Lifescience Private Limited has a workforce of 50 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
50
Active EPFO establishments
1
Employee growth
-12.28%

GST

Safal Lifescience has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
24AAXCS1015M1Z1GujaratActive01 Jul 2017
19AAXCS1015M1ZSWest BengalActive22 Aug 2019

To see the full GST registrations and return filing status of Safal Lifescience Private Limited, buy the company report.

Recent activity

Safal Lifescience Private Limited has 6 board changes on record since 2019: 2 appointments and 4 cessations. The latest: Dasharathbhai Narsangbhai Chaudhary ceased to be Director on 16 Mar 2020.

AGM
Safal Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Safal Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Dasharathbhai Narsangbhai Chaudhary ceased to be Director.
Ceased
Vishal Dasharathbhai Chaudhary ceased to be Director.
Ceased
Jignesh Navinchandra Mehta ceased to be Additional Director.
Ceased
Navinbhai Manilal Mehta ceased to be Additional Director.
Charges
A charge registered on 19 Apr 2018 via Charge ID 100171479 with State Bank Of India was fully satisfied on 15 May 2019.
Appointed
Jignesh Navinchandra Mehta was appointed as Director.
Appointed
Navinbhai Manilal Mehta was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 9.50 Cr with Charge ID 100171479 was registered on 19 Apr 2018.
Incorporation
19 May 2016
Safal Lifescience Private Limited was registered on 19 May 2016 with Roc Ahmedabad & aged 10 years 5 months as per MCA records.

Frequently asked questions

Safal Lifescience is an active private limited company based in Kadi, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 May 2016 (10+ years old) and is registered under CIN U24230GJ2016PTC092075.

Safal Lifescience has 2 current directors:

The latest financial statements of Safal Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Safal Lifescience is 24AAXCS1015M1Z1, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 19AAXCS1015M1ZS (West Bengal).

The CIN (Corporate Identification Number) of Safal Lifescience is U24230GJ2016PTC092075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Safal Lifescience has 29 court cases on record: 5 filed by the company and 24 filed against it. 6 are pending. Most are in the district courts.

Safal Lifescience was incorporated on 19 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Safal Lifescience has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2020.

The peers of Safal Lifescience by revenue are Meditech Devices Private Limited, Neel Pigments Private Limited, Goodie International Private Limited, KSJN Chemicals Private Limited, Rapross Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Dasharathbhai Narsangbhai Chaudhary ceased to be Director on 16 Mar 2020. Vishal Dasharathbhai Chaudhary ceased to be Director on 16 Mar 2020. Jignesh Navinchandra Mehta ceased to be Additional Director on 30 Sep 2019. Safal Lifescience has 6 board changes on record in total.

Yes, Safal Lifescience is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-14-0002057).

Safal Lifescience has 4 MSME Form 1 returns on record between 2020 and 2022, listing 274 overdue payments to 18 micro and small suppliers. The latest return was filed on 30 Apr 2022.